AllNewsPostsPress Releases
Accuro epidural guidance device demonstrated superior for spinal anesthesia administration compared to palpation and conventional ultrasound in a parturient with extreme obesity

Accuro epidural guidance device demonstrated superior for spinal anesthesia administration compared to palpation and conventional ultrasound in a parturient with extreme obesity

Accuro's integration of artificial intelligence with ultrasound (AI-US) provides detailed ultrasound image-analysis pivotal in complex clinical scenarios. CHARLOTTESVILLE, VA, August 16, 2022 — RIVANNA®, developers of world-first, imaging-based medical solutions,...

AllPress Releases
RIVANNA appoints medical technology veteran Nikki Troiano Gainey to board of directors

RIVANNA appoints medical technology veteran Nikki Troiano Gainey to board of directors

Medical Technology Leader to Advise Commercialization Strategy for Next-Generation Products   CHARLOTTESVILLE, VA, July 7, 2022 — RIVANNA®, developers of world-first, imaging-based medical solutions, has named Nikki Troiano Gainey, a MedTech corporate and...

AllNewsPress Releases
RIVANNA announces partnership with BOMImed to increase distribution of Accuro in Canada

RIVANNA announces partnership with BOMImed to increase distribution of Accuro in Canada

CHARLOTTESVILLE, VA, DECEMBER 1, 2021 — RIVANNA®, developers of world-first, imaging-based medical solutions, announced they have entered into a partnership with BOMImed, a recognized manufacturer of anesthesia and critical care related consumables to represent and...

AllNewsPress Releases
RIVANNA’s Accuro shows statistically significant efficacy and safety for combined spinal-epidural anesthesia

RIVANNA’s Accuro shows statistically significant efficacy and safety for combined spinal-epidural anesthesia

CHARLOTTESVILLE, VA, SEPTEMBER 13, 2021 — RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the results of a recent randomized controlled trial (RCT) showing that Accuro® automated spinal navigation system significantly enhanced...

AllPress Releases
RIVANNA’s Accuro automatically identifies and measures epidural space depth with accuracy equivalent to standard ultrasound in obese pregnant women

RIVANNA’s Accuro automatically identifies and measures epidural space depth with accuracy equivalent to standard ultrasound in obese pregnant women

CHARLOTTESVILLE, VA, September 8, 2021 — RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the results of a prospective, double-blind study demonstrating that the Accuro® Epidural Guidance device with SpineNav3D™...

AllPosts
Automated Ultrasound Guidance Streamlines Epidural Placement for Challenging Patients in Labor

Automated Ultrasound Guidance Streamlines Epidural Placement for Challenging Patients in Labor

  Accuro guidance helps eliminate challenges associated with epidural placement for high BMI patients. By Dr. Regina Fragneto   It’s no secret that childbirth hurts. For most women, it is characterized by intense pain and pressure in the lower abdomen and back...

AllNewsPress Releases
RIVANNA’s Accuro product-line expansion fortified with European notice of allowance

RIVANNA’s Accuro product-line expansion fortified with European notice of allowance

CHARLOTTESVILLE, VA, JUNE 2, 2021—RIVANNA®, developers of world-first, imaging-based medical solutions, announced the European Patent Office has issued RIVANNA a notice of allowance for European patent application No. 13803513.4 entitled “Ultrasound Imaging of...

AllNewsPress Releases
RIVANNA announces alliance with Tri-anim Health Services to increase nationwide distribution of Accuro

RIVANNA announces alliance with Tri-anim Health Services to increase nationwide distribution of Accuro

CHARLOTTESVILLE, VA, MAY 4, 2021—RIVANNA®, developers of world-first, imaging-based medical solutions, announced they have entered into a partnership with Tri-anim Health Services, a specialty distributor of respiratory, anesthesia, and critical-care supplies, to...

AllNewsPress Releases
United Kingdom’s NICE publishes Medtech innovation briefing on the use of Accuro

United Kingdom’s NICE publishes Medtech innovation briefing on the use of Accuro

UK's NICE Publishes Medtech Innovation Briefing on Accuro for Guiding Epidural or Spinal Anaesthesia to Reduce Needle Insertions Compared with Palpation Alone in People with Obesity CHARLOTTESVILLE, VA., April 13, 2021—RIVANNA®, developers of world-first,...

AllNewsPress Releases
Accuro second generation scanning the spine with needle track needle visualization
RIVANNA launches Accuro Second Generation with Multi-Frequency Image Reconstruction and AI-Based Spine Recognition

RIVANNA launches Accuro Second Generation with Multi-Frequency Image Reconstruction and AI-Based Spine Recognition

RIVANNA Launches Accuro Second Generation With BoneEnhance® Multi-Frequency Image Reconstruction And SpineNav3D™ AI-Based Spine Recognition CHARLOTTESVILLE, VA., March 23, 2021 — RIVANNA®, developers of world-first, imaging-based medical solutions, announces...

AllNewsPress Releases
RIVANNA launches second generation Accuro with thoracic functionality and globally enhanced performance

RIVANNA launches second generation Accuro with thoracic functionality and globally enhanced performance

Real-time needle guidance for paramedian epidural and spinal anesthesia maximizes image guidance efficiency CHARLOTTESVILLE, VA., November 16, 2020 – RIVANNA® today announced launch of its second-generation Accuro® automated spinal navigation system, combining...

AllPosts
Image-Guided Epidural Placement in Parturient Presenting Post-Trauma Spinal Instrumentation

Image-Guided Epidural Placement in Parturient Presenting Post-Trauma Spinal Instrumentation

"As an anesthesiologist performing epidurals and spinals, we're one of the few specialties not using imaging technology regularly to find the epidural space; this is an advancement that is due in our specialty." —Stephen Garber MDAnesthesiologist, Medical Director...

AllNewsPress Releases
RIVANNA to commercialize low-cost, bedside system to minimize non-diagnostic BMTB acquisition

RIVANNA to commercialize low-cost, bedside system to minimize non-diagnostic BMTB acquisition

Palpation alone to determine the appropriate needle trajectory is recognized as a contributing factor in the acquisition of non-diagnostic BMTB specimens [1, 2].   CHARLOTTESVILLE, VA, May 20, 2020 — RIVANNA announced that the company was awarded a $1.5M...

AllPress Releases
RIVANNA prepares for European market adoption of Accuro with the appointment of a new Vice President of Sales, Europe, the Middle East, and Africa (EMEA)

RIVANNA prepares for European market adoption of Accuro with the appointment of a new Vice President of Sales, Europe, the Middle East, and Africa (EMEA)

RIVANNA prepares for European Market adoption of Accuro™ with the appointment of a new Vice President of Sales, Europe, the Middle East, and Africa (EMEA)

AllPress Releases
Accuro Highlighted in “AORA 2015” scientific presentation by Anand M. Sardesai, MD, anesthesiologist, Cambridge (UK) University Hospital: “Advances in Ultrasound Machine Technology and Future Trends”

Accuro Highlighted in “AORA 2015” scientific presentation by Anand M. Sardesai, MD, anesthesiologist, Cambridge (UK) University Hospital: “Advances in Ultrasound Machine Technology and Future Trends”

Accuro™ highlighted in “AORA 2015” scientific presentation by Anand M. Sardesai, MD, Anesthesiologist, Cambridge (UK) University Hospital: “Advances in Ultrasound Machine Technology and Future Trends”